Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Oculis Holding AG (OCSAW)

6-K Earnings release confidence 95% filed 2026-08-06 EX-99.3

Oculis Holding AG reported Q2 2026 financial results, including condensed consolidated financial statements showing a cash position of $282.3 million and detailed operating expenses. The earnings announcement includes balance sheet and income statement data typical of a quarterly financial results disclosure.

View raw filing on EDGAR →

TerrAscend Corp. (TSNDF)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

TerrAscend issued a press release on August 6, 2026 announcing Q2 2026 financial results, disclosing net revenue of $67.1 million, gross profit margin of 54.0%, Adjusted EBITDA of $17.7 million, and 16 consecutive quarters of positive operating cash flow.

View raw filing on EDGAR →

TerrAscend Corp. (TSNDF)

8-K Exec appointment confidence 95% filed 2026-08-06 Item 5.02

On August 5, 2026, the Board appointed Ziad Ghanem, the Company's President and CEO since March 2023, to serve as a member of the Board, effective immediately, with no additional compensation.

View raw filing on EDGAR →

ALTA EQUIPMENT GROUP INC. (ALTG-PA)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

Alta Equipment Group Inc. issued a press release announcing its results of operations and financial condition for the quarter ended June 30, 2026, including detailed financial statements, segment performance metrics, CEO commentary, and full-year 2026 guidance.

View raw filing on EDGAR →

ALTA EQUIPMENT GROUP INC. (ALTG-PA)

8-K Exec appointment confidence 95% filed 2026-08-06 Item 5.02

David Turner was elected to the Board of Directors effective August 3, 2026, filling a newly created director position as a Class II director.

View raw filing on EDGAR →

Surrozen, Inc./DE (SRZNW)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02. The press release announces financial results including revenue ($5.0M collaboration/license revenue), operating expenses (R&D $8.5M, G&A $6.9M), and net income ($50.2M, driven largely by non-cash gains on fair value changes). The filing includes unaudited condensed consolidated statements of operations and comprehensive loss, which are standard components of an earnings disclosure. Material to investors as it provides quarterly financial performance and updates on clinical development milestones.

View raw filing on EDGAR →

American Healthcare REIT, Inc. (AHR)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

American Healthcare REIT issued an earnings release on August 6, 2026, announcing second quarter 2026 financial results including GAAP net income of $0.16 per diluted share, NFFO of $0.54 per diluted share, and 13.2% portfolio Same-Store NOI growth. The company also raised full-year 2026 guidance for NFFO per diluted share to $2.15–$2.19 and Same-Store NOI growth to 11.0%–13.0%.

View raw filing on EDGAR →

Zoetis Inc. (ZTS)

8-K Exec appointment confidence 95% filed 2026-08-06 Item 5.02

James Saccaro's appointment as Executive Vice President, Chief Financial Officer and Chief Operating Officer effective August 17, 2026 is the principal disclosed action. While the filing also discloses Wetteny Joseph's departure, the appointment of a new CFO/COO at a major public company (Zoetis, a large-cap animal health leader) is the salient event. The compensation details (base salary $1M, LTI target $5M, make-whole awards totaling $7.5M) and his extensive background at GE HealthCare and Baxter underscore the materiality of this executive leadership transition.

View raw filing on EDGAR →

Phunware, Inc. (PHUN)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a clear earnings release disclosing Phunware's financial results for Q2 2026 and the first six months of 2026. The press release (Exhibit 99.1) reports net revenue of $0.8 million (up 76% YoY), gross margin of 69%, net loss of $5.2 million, and cash position of $92.1 million with no debt. The filing is made under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases, and the company explicitly states the press release is "furnished herewith as Exhibit 99.1."

View raw filing on EDGAR →

REVELATION BIOSCIENCES, INC. (REVBW)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a straightforward earnings release disclosing financial results for the three and six months ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents consolidated statements of operations and balance sheets, net loss figures ($3.3M and $6.3M respectively), cash position ($11.5M), and operational highlights including clinical trial progress. The disclosure is material to investors assessing the company's financial condition and runway.

View raw filing on EDGAR →

Exzeo Group, Inc. (XZO)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

Exzeo Group issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing key metrics including revenue of $57.8 million, net income of $23.3 million, and earnings per share of $0.26. The earnings release is furnished as Exhibit 99.1 to the 8-K filing under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.

View raw filing on EDGAR →

MBIA INC (MBI)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

MBIA issued a press release on August 6, 2026 announcing quarterly financial results for the period ended June 30, 2026, with the financial results report attached as Exhibit 99.1.

View raw filing on EDGAR →

Drilling Tools International Corp (DTI)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure states that "Drilling Tools International Corporation (the 'Company') issued a press release announcing the Company's financial and operating results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue breakdowns ($38.1M total revenue), net loss ($1.8M), EPS ($0.05 loss per share), and full-year 2026 guidance reaffirmed by management. This is a material quarterly earnings announcement typical of Item 2.02 disclosures.

View raw filing on EDGAR →

HCI Group, Inc. (HCIIP)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

HCI Group disclosed its quarterly and six-month financial results for the period ended June 30, 2026, including pre-tax income of $111 million and $226 million respectively, diluted EPS of $5.60 and $11.05, and detailed revenue and expense breakdowns. The Item 2.02 disclosure explicitly states "we released our earnings for the three and six months ended June 30, 2026" and references the earnings release as Exhibit 99.1, which is a standard earnings release format with management commentary, financial statements, and conference call details.

View raw filing on EDGAR →

STERIS plc (STE)

8-K Shareholder vote confidence 98% filed 2026-08-06 Item 5.07

This is a classic Item 5.07 disclosure of shareholder voting results from STERIS plc's 2026 Annual General Meeting held July 31, 2026. The filing reports final voting tallies on seven matters: election of nine board directors, ratification of Ernst & Young LLP as independent auditor, appointment of Ernst & Young Chartered Accountants as statutory auditor, auditor compensation authorization, non-binding say-on-pay vote, renewal of board authority to issue shares, and renewal of pre-emption rights opt-out. All proposals passed with substantial majorities. This is material as it reflects shareholder governance decisions and board composition changes.

View raw filing on EDGAR →

NETGEAR, INC. (NTGR)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

NETGEAR issued a press release on August 6, 2026 announcing its financial results for the second fiscal quarter ended June 28, 2026, disclosing Q2 2026 net revenue of $168.6 million, GAAP operating loss of $(8.4) million, and non-GAAP operating income of $4.0 million, along with segment performance and forward guidance for Q3 2026.

View raw filing on EDGAR →

NETGEAR, INC. (NTGR)

8-K Exec appointment confidence 95% filed 2026-08-06 Item 5.02

Douglas Murray was elected to the Board of Directors on August 3, 2026, effective immediately. Murray is an enterprise networking and security veteran with 30 years of experience at companies including Juniper Networks and Extreme Networks, and is the current CEO of Auvik.

View raw filing on EDGAR →

Apple Hospitality REIT, Inc. (APLE)

8-K Dilutive issuance confidence 75% filed 2026-08-06

Apple Hospitality REIT amended its equity distribution agreement on August 6, 2026, to continue selling up to $500 million of common shares through multiple agents. While the amendment itself is primarily administrative (updating agent definitions), the underlying equity distribution program represents a material dilutive issuance arrangement that allows the company to raise capital through at-the-market or negotiated offerings. This is material to investors as it signals the company's capital-raising strategy and potential dilution to existing shareholders.

View raw filing on EDGAR →

ACRES Commercial Realty Corp. (ACR-PD)

8-K M&A activity confidence 95% filed 2026-08-06 Item 2.01

ACRES Commercial Realty Corp. completed a merger and internalization transaction on August 6, 2026, acquiring ACRES Capital Corp. (its external manager) through a merger with a subsidiary. The transaction resulted in the issuance of 7,478,462 shares of common stock as merger consideration and the termination of the external management agreement, fundamentally changing the company's governance and operational structure.

View raw filing on EDGAR →

ACRES Commercial Realty Corp. (ACR-PD)

8-K Debt Issuance confidence 94% filed 2026-08-06 Item 1.01

ACRES Commercial Realty Corp. completed two material debt transactions: (1) assumption of a $185 million term loan facility with MassMutual and other lenders, and (2) completion of a $200 million private placement of 8.625% Senior Secured Notes due 2031. These transactions created substantial new direct financial obligations to support the merger and internalization.

View raw filing on EDGAR →

ACRES Commercial Realty Corp. (ACR-PD)

8-K Exec Compensation confidence 95% filed 2026-08-06 Item 5.02

ACRES Commercial Realty Corp. entered into employment agreements with seven executive officers (Fogel, Fentress, Reasoner, Jesberger, Brengel, Blackwell, and Persaud) effective August 6, 2026, in connection with the merger and internalization. The agreements specify base salaries ranging from $300,000 to $600,000, target annual cash bonuses of at least 50% of base salary, severance provisions of 1.5x to 2x base salary plus target bonus depending on change-of-control timing, and equity eligibility.

View raw filing on EDGAR →

KLA CORP (KLAC)

8-K Dividend Distribution confidence 98% filed 2026-08-06 Item 8.01

KLA's Board declared a quarterly cash dividend of $0.23 per share, payable September 1, 2026 to shareholders of record as of August 17, 2026. This is a routine but material dividend declaration that affects shareholder value and is disclosed via press release attached as Exhibit 99.1.

View raw filing on EDGAR →

indie Semiconductor, Inc. (INDI)

8-K Earnings release confidence 97% filed 2026-08-06 Item 2.02

indie Semiconductor issued a press release on August 6, 2026 announcing Q2 2026 financial results, including revenue of $64.0 million (up 24% Y-o-Y), GAAP operating loss of $35.1 million, and Non-GAAP operating loss of $8.9 million, along with Q3 2026 revenue guidance of $67–$73 million.

View raw filing on EDGAR →

TCGX Acquisition Corp.

8-K M&A activity confidence 85% filed 2026-08-06 Item 1.01

TCGX Acquisition Corp. consummated its initial public offering on August 6, 2026, raising $86.25 million through the issuance of 8,625,000 Class A ordinary shares at $10.00 per share and entering into material definitive agreements (Underwriting Agreement, Investment Management Trust Agreement, Registration Rights Agreement, Private Placement Shares Purchase Agreements, and Forward Purchase Agreement) in connection with the offering.

View raw filing on EDGAR →

TCGX Acquisition Corp.

8-K Dilutive issuance confidence 95% filed 2026-08-06 Item 3.02

TCGX Acquisition Corp. completed an unregistered private placement of 522,500 Class A ordinary shares at $10.00 per share ($5.225 million aggregate) to the Sponsor and Jefferies LLC, executed simultaneously with the IPO closing pursuant to Section 4(a)(2) exemption from registration.

View raw filing on EDGAR →

TCGX Acquisition Corp.

8-K Exec appointment confidence 92% filed 2026-08-06 Item 5.02

TCGX Acquisition Corp. appointed three independent directors—Andrew Cheng, M.D., Ph.D., Ying Huang, Ph.D., and Wei Lin, M.D.—to the Board effective August 4, 2026, in connection with the IPO, establishing the initial board composition and governance structure of the newly public SPAC.

View raw filing on EDGAR →

TCGX Acquisition Corp.

8-K Governance Other confidence 75% filed 2026-08-06 Item 5.03

TCGX Acquisition Corp. adopted an Amended and Restated Memorandum and Articles of Association effective August 4, 2026, in connection with the Company's IPO, establishing the foundational corporate governance structure and defining shareholder rights and obligations for the newly public SPAC.

View raw filing on EDGAR →

MERCER INTERNATIONAL INC. (MERC)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

Mercer International Inc. announced its second quarter 2026 financial results via press release on August 6, 2026, disclosing operating EBITDA of negative $21.0 million, net loss of $76.0 million, and detailed segment performance. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1, meeting the definition of earnings_release.

View raw filing on EDGAR →

Verrica Pharmaceuticals Inc. (VRCA)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a standard earnings release disclosing Verrica's financial results for Q2 2026 and six months ended June 30, 2026. The press release (Exhibit 99.1) reports total revenue of $5.9 million in Q2 2026, U.S. YCANTH net product revenue of $5.1 million, and a net loss of $13.2 million for the quarter. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings disclosures.

View raw filing on EDGAR →

Bright Mountain Media, Inc. (BMTM)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a clear earnings release disclosing Bright Mountain Media's financial results for Q2 2026 and the six-month period ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents consolidated statements of operations, balance sheets, and detailed revenue/expense breakdowns. The company reports a net loss of $3.2 million for Q2 2026 (improved 22% from prior year) and $4.5 million for the six-month period (improved 38% from prior year), along with adjusted EBITDA metrics. This is a material disclosure affecting investor assessment of the registrant's financial performance and operational results.

View raw filing on EDGAR →

KORN FERRY (KFY)

8-K Debt Issuance confidence 75% filed 2026-08-06 Item 8.01

Korn Ferry issued a conditional notice of redemption for $400 million of 4.625% Senior Notes due 2027, conditioned on completing debt financing transactions to raise at least $400 million in proceeds by August 18, 2026. While the primary action is redemption of existing debt, the filing centers on the Company's plan to refinance this obligation through new debt issuance, making this fundamentally a debt capital transaction that creates new direct financial obligations to replace the redeemed notes.

View raw filing on EDGAR →

Organogenesis Holdings Inc. (ORGO)

8-K Dilutive issuance confidence 92% filed 2026-08-06 Item 1.01

Organogenesis entered into an At-the-Market (ATM) Sales Agreement on August 6, 2026, authorizing the sale of up to $75 million in Class A common stock through agents BTIG and Citizens JMP Securities. ATM offerings are unregistered equity issuances that create dilution risk for existing shareholders and are a common capital-raising mechanism at small- and mid-cap issuers. The material amount ($75M) and the explicit authorization to sell shares "from time to time" through registered agents make this a dilutive issuance event.

View raw filing on EDGAR →

GMF Leasing LLC

8-K Debt Issuance confidence 92% filed 2026-08-06 Item 1.01

GMF Leasing LLC, as depositor, entered into a material definitive agreement to issue approximately $1 billion in asset-backed notes across multiple classes (Class A-1 through Class C) backed by automobile leases. The transaction involves an Underwriting Agreement dated August 4, 2026, with multiple underwriters (BMO Capital Markets, Credit Agricole, Goldman Sachs, RBC Capital Markets, and others) for the public sale of these notes through a securitization trust (GM Financial Automobile Leasing Trust 2026-3).

View raw filing on EDGAR →

Morgan Stanley Direct Lending Fund (MSDL)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

Morgan Stanley Direct Lending Fund issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing net investment income of $0.45 per share, net asset value of $19.50 per share, and declaring a regular dividend of $0.45 per share.

View raw filing on EDGAR →

Silver Capital Holdings LLC

8-K Exec departure confidence 75% filed 2026-08-06 Item 5.02

David Miller's resignation as Co-Chief Executive Officer effective December 31, 2026, is the principal disclosed action. Although the filing also includes the appointment of Justin Betzen as co-President and co-Chief Operating Officer, the Item 5.02 disclosure centers on Miller's departure from the co-CEO role and the resulting succession plan where Vivek Bantwal becomes sole CEO. This is a material executive transition at the principal executive officer level.

View raw filing on EDGAR →

Xponential Fitness, Inc. (XPOF)

8-K Earnings release confidence 98% filed 2026-08-06 Item 2.02

This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026, disclosed via Item 2.02 and furnished as Exhibit 99.1. The press release announces financial results including revenue of $66.0 million (down 13%), net loss of $4.8 million, and revised full-year 2026 guidance showing material declines in revenue (down 19% at midpoint) and Adjusted EBITDA (down 16% at midpoint). The disclosure is material as it reflects significant deterioration in financial performance and reduced forward guidance.

View raw filing on EDGAR →

Goldman Sachs Private Middle Market Credit II LLC

8-K Exec departure confidence 75% filed 2026-08-06 Item 5.02

David Miller's resignation as Co-Chief Executive Officer and co-principal executive officer, effective December 31, 2026, is the principal disclosed action. While the filing also includes Justin Betzen's appointment as co-President and co-Chief Operating Officer, the central narrative focuses on Miller's departure and the resulting succession plan (Vivek Bantwal becoming sole CEO). This is material to investors as it involves a change in senior executive leadership of the company.

View raw filing on EDGAR →

Rare Earths Americas, Inc. (REA)

8-K M&A activity confidence 85% filed 2026-08-06 Item 1.01

The Third Amendment grants FRE US (a subsidiary of Rare Earths Americas) an option to acquire and assume the Weyerhaeuser Mining Lease, which FRE US exercised on July 31, 2026. The transaction involves material consideration ($375,000 cash plus $2,000,000 in common stock issued in a private placement) and acquisition of a mining lease asset. This constitutes entry into a material acquisition activity under Item 1.01, though the transaction is structured as an option exercise and lease assignment rather than a traditional M&A deal.

View raw filing on EDGAR →

Goldman Sachs Private Credit Corp.

8-K Exec departure confidence 75% filed 2026-08-06 Item 5.02

David Miller's resignation as Co-Chief Executive Officer effective December 31, 2026, is the principal disclosed action. While the filing also includes Justin Betzen's appointment as co-President and co-Chief Operating Officer, the departure of a co-CEO is the more material and salient event. Miller's transition to advisory roles and the succession plan (Vivek Bantwal becoming sole CEO) are secondary consequences of the departure.

View raw filing on EDGAR →

Cantor Fitzgerald Income Trust, Inc. (CFTR-PA)

8-K Dividend Distribution confidence 98% filed 2026-08-06 Item 7.01

The filing discloses a declaration of distributions by the board of directors for multiple share classes and operating partnership units of Cantor Fitzgerald Income Trust, Inc., with specific per-unit amounts (ranging from $0.08646 to $0.08650) representing 5.00% of NAV on an annual basis, payable on or about August 6, 2026. This is a routine but material dividend distribution disclosure typical of closed-end funds and trusts.

View raw filing on EDGAR →

Phillip Street BDC LLC

8-K Exec departure confidence 75% filed 2026-08-06 Item 5.02

David Miller's resignation as Co-Chief Executive Officer effective December 31, 2026, is the principal disclosed action. Although the filing also includes Justin Betzen's appointment as co-President and co-Chief Operating Officer, the departure of a co-CEO is the more material event affecting the registrant's leadership structure. The filing explicitly states Miller's resignation and the transition of his duties to Vivek Bantwal, who will become sole CEO.

View raw filing on EDGAR →

West Bay BDC LLC

8-K Exec departure confidence 75% filed 2026-08-06 Item 5.02

David Miller's resignation as Co-Chief Executive Officer effective December 31, 2026, is the principal disclosed action. While the filing also includes an appointment (Justin Betzen as co-President and co-COO) and a promotion (Vivek Bantwal becoming sole CEO), the opening and most substantive disclosure concerns Miller's departure from the co-CEO role. The departure of a co-principal executive officer is material to investors assessing leadership continuity.

View raw filing on EDGAR →

EIDP, Inc. (CTA-PA)

8-K M&A activity confidence 92% filed 2026-08-06 Item 8.01

Corteva is executing a material separation transaction to split into two independent publicly traded companies: one retaining crop protection and the other (Vylor) retaining the seed business. The filing announces the commencement of exchange offers and consent solicitations for EIDP Notes in connection with this planned separation, expected to close October 1, 2026.

View raw filing on EDGAR →

Solid Biosciences Inc. (SLDB)

8-K Dilutive issuance confidence 92% filed 2026-08-06 Item 8.01

The Company filed a prospectus supplement on August 6, 2026 to offer and sell up to $200.0 million of common stock pursuant to an Amended and Restated Sales Agreement with Jefferies LLC. This represents a material dilutive equity issuance under an ATM (at-the-market) offering program, with the Company having already issued $85.0 million in shares under the prior prospectus supplement. The filing of a new prospectus supplement to increase the offering capacity signals a significant capital raise that would materially dilute existing shareholders.

View raw filing on EDGAR →

REZOLVE AI PLC (RZLVW)

6-K Other material confidence 72% filed 2026-08-06 EX-99.1

This press release discloses Rezolve Ai's commentary on a rejected merger proposal with Commerce.com, reaffirms its FY2026 revenue guidance of approximately $360 million (7.5x FY2025), and reports preliminary H1 2026 revenue of approximately $127 million (nearly 20x YoY growth). While the release contains forward-looking guidance and strategic positioning, it does not constitute a discrete earnings release (no audited results), M&A activity (the proposal was rejected in April), or a periodic financial report. The material substance—reaffirmed guidance and preliminary H1 results—is operational and strategic commentary rather than a formal financial disclosure, making it a material event that does not fit neatly into the standard taxonomy.

View raw filing on EDGAR →

PROCORE TECHNOLOGIES, INC. (PCOR)

8-K Debt Issuance confidence 95% filed 2026-08-06 Item 1.01

Procore completed a private offering of $950 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 on August 6, 2026. The notes are general senior unsecured obligations with conversion mechanics, redemption provisions, and capped call transactions, with net proceeds of approximately $804.4 million to be used for the DroneDeploy acquisition, capped call transactions, share repurchases, and general corporate purposes.

View raw filing on EDGAR →

DESTINATION XL GROUP, INC. (DXLG)

8-K Exec appointment confidence 95% filed 2026-08-06 Item 5.02

The filing discloses the appointment of Lionel F. Conacher, the Company's Chairman, as Interim Chief Executive Officer effective August 12, 2026, following the retirement of Harvey S. Kanter. While the section also covers Kanter's departure, the principal disclosed action centers on Conacher's appointment to the CEO role, supported by detailed compensation terms ($80,000/month base salary plus $15,000/month in equity) and governance changes (appointment of Lead Independent Director, committee reassignments). This is a material executive appointment at a critical juncture for the company.

View raw filing on EDGAR →

Tango Therapeutics, Inc. (TNGX)

8-K Exec departure confidence 92% filed 2026-08-06 Item 5.02

Dr. Barbara Weber's employment as Executive Chair ended on August 3, 2026, and she resigned from all officer and board member positions. While the disclosure includes severance and compensation details, the principal disclosed action is her departure from the company and board. The filing emphasizes the termination of employment and resignation from all positions, making this fundamentally an executive departure event.

View raw filing on EDGAR →

Arcturus Therapeutics Holdings Inc. (ARCT)

8-K Earnings release confidence 95% filed 2026-08-06 Item 2.02

This is a standard earnings release disclosing Arcturus' financial results for Q2 2026 (quarter ended June 30, 2026), including revenue, R&D expenses, net loss, and balance sheet metrics. The press release (Exhibit 99.1) announces quarterly financial results and provides corporate updates on pipeline progress. This is a material disclosure affecting investor assessment of the company's financial condition and operational progress.

View raw filing on EDGAR →